Bibliographic information
GuidelineMedical eligibility criteria for contraceptive use, 6th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization
Recommendation
Maintained
Women with known dyslipidaemias without other known cardiovascular risk factors can generally use combined hormonal contraceptives (MEC Category 2).
Certainty of evidence
Very low
Notes and Remarks
Routine screening is not appropriate because of the rarity of the condition and the high cost of screening. Increased levels of total cholesterol, low-density lipoprotein (LDL) and triglycerides, as well as a decreased level of high-density lipoprotein (HDL), are known risk factors for CVD. Women with known severe genetic lipid disorders are at much higher lifetime risk for CVD and may warrant further clinical consideration.
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Medical eligibility criteria for contraceptive use
Year2015
InstitutionWorld Health Organization